LABFF vs LLY: Which Stock is Better?

Side-by-side comparison of Laboratorios Farmaceuticos Rovi, S.A./Adr and Eli Lilly & Co in 2026

Comparison Updated:

LABFF

Laboratorios Farmaceuticos Rovi, S.A./Adr

$90.61

LLY

Eli Lilly & Co

$927.03

Key Metrics Comparison

MetricLABFFLLYWinner
Market Cap$4.63B$809.09BLLY
P/E Ratio28.9539.32LABFF
EPS (TTM)$3.13$22.99LLY
Revenue Growth0.1%0.4%LLY
Gross Margin63.4%83.0%LLY

Analyze LABFF

Full quant analysis

Analyze LLY

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LABFF or LLY a better investment?

Comparing LABFF and LLY: Laboratorios Farmaceuticos Rovi, S.A./Adr has a market cap of $4.63B while Eli Lilly & Co has $809.09B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LABFF and LLY?

LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LABFF or LLY?

Based on P/E ratios, LABFF trades at a lower multiple (28.9x vs 39.3x).

Which is growing faster: LABFF or LLY?

LLY has higher revenue growth at 0.4% vs 0.1% for LABFF.

Which company is more profitable: LABFF or LLY?

Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 63.4% for LABFF.

Which is the larger company: LABFF or LLY?

Eli Lilly & Co (LLY) is larger with a market cap of $809.09B compared to $4.63B for LABFF.

Should I buy LABFF or LLY in 2026?

Both LABFF and LLY have investment merit. LABFF trades at $90.61 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LABFF and LLY stock?

Key differences: Market Cap ($4.63B vs $809.09B), P/E Ratio (28.9x vs 39.3x), Revenue Growth (0.1% vs 0.4%), Gross Margin (63.4% vs 83.0%).

Popular Stock Comparisons